Rapid progression to decompensated cirrhosis, liver transplant, and death in HIV-infected men after primary Hepatitis C virus infection

Clinical Infectious Diseases

Volumn 56, Issue 7, 2013, Pages 1038-1043

  Fierer, Daniel S ^a   Dieterich, Douglas T ^b   Fiel, M Isabel ^a   Branch, Andrea D ^b   Marks, Kristen M ^c   Fusco, Dahlene N ^c   Hsu, Ricky ^d   Smith, Davey M ^e,f   Fierer, Joshua ^e,f  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b Department of Medicine   (United States)

^c WEILL CORNELL MEDICAL COLLEGE   (United States)

^d NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f VA SAN DIEGO HEALTHCARE SYSTEM   (United States)

Author keywords

HIV infection AIDS; Immunocompromise; Liver failure; Men who have sex with men; Primary acute hepatitis C infection

Indexed keywords

ABACAVIR; ALANINE AMINOTRANSFERASE; ALCOHOL; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; DIDANOSINE; EMTRICITABINE; LAMIVUDINE; METHAMPHETAMINE; PEGINTERFERON; RITONAVIR; STAVUDINE; TENOFOVIR; VITAMIN; ZIDOVUDINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALCOHOL CONSUMPTION; ANTIVIRAL THERAPY; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BILIRUBIN BLOOD LEVEL; CASE REPORT; CD4 LYMPHOCYTE COUNT; COHORT ANALYSIS; DEATH; DECOMPENSATED LIVER CIRRHOSIS; DISEASE COURSE; DRUG WITHDRAWAL; HEPATITIS C; HISTOPATHOLOGY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; JAUNDICE; LIVER BIOPSY; LIVER FAILURE; LIVER TRANSPLANTATION; MALE; PRIORITY JOURNAL; SINGLE DRUG DOSE; UNSPECIFIED SIDE EFFECT; VIRUS LOAD;

ADULT; CD4 LYMPHOCYTE COUNT; COHORT STUDIES; FATAL OUTCOME; HEPATITIS C; HISTOCYTOCHEMISTRY; HIV INFECTIONS; HUMANS; LIVER; LIVER CIRRHOSIS; LIVER FAILURE; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; NEW YORK CITY; TIME FACTORS;

EID: 84875028702     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/cis1206     Document Type: Article

References (28)

1. Branch AD, Van Natta ML, Vachon ML, Dieterich DT, Meinert CL, Jabs DA. Mortality in hepatitis C virus-infected patients with a diagnosis of AIDS in the era of combination antiretroviral therapy. Clin Infect Dis 2012; 55: 137-44.
2. Thein HH, Yi Q, Dore GJ, Krahn MD. Natural history of hepatitis C virus infection in HIV-infected individuals and the impact of HIV in the era of highly active antiretroviral therapy: a meta-analysis. AIDS 2008; 22: 1979-91.
3. Thomas DL, Vlahov D, Solomon L, et al. Correlates of hepatitis C virus infections among injection drug users. Medicine (Baltimore) 1995; 74: 212-20.
4. Benhamou Y, Bochet M, Di Martino V, et al. Liver fibrosis progression in human immunodeficiency virus and hepatitis C virus coinfected patients. Hepatology 1999; 30: 1054-8.
5. van de Laar T, Pybus O, Bruisten S, et al. Evidence of a large, international network of HCV transmission in HIV-positive men who have sex with men. Gastroenterology 2009; 136: 1609-17.
6. Fierer DS, Uriel AJ, Carriero DC, et al. Sexual transmission of hepatitis C virus (HCV) among HIV-infected men who have sex with men (MSM), New York City, 2005-2010. MMWR Morb Mortal Wkly Rep 2011; 60: 945-50.
7. Kamal SM, Turner B, He Q, et al. Progression of fibrosis in hepatitis C with and without schistosomiasis: correlation with serum markers of fibrosis. Hepatology 2006; 43: 771-9.
8. Larghi A, Zuin M, Crosignani A, et al. Outcome of an outbreak of acute hepatitis C among healthy volunteers participating in pharmacokinetics studies. Hepatology 2002; 36: 993-1000.
9. Scheuer PJ, Standish RA, Dhillon AP. Scoring of chronic hepatitis. Clin Liver Dis 2002; 6: 335-47, v-vi.
10. Fierer DS, Uriel AJ, Carriero DC, et al. Liver fibrosis during an outbreak of acute hepatitis C virus infection in HIV-infected men: a prospective cohort study. J Infect Dis 2008; 198: 683-6.
11. Bottieau E, Apers L, Van Esbroeck M, Vandenbruaene M, Florence E. Hepatitis C virus infection in HIV-infected men who have sex with men: sustained rising incidence in Antwerp, Belgium, 2001-2009. Euro Surveill 2010; 15: 19673.
12. Fierer DS, Mullen MP, Dieterich DT, Isabel Fiel M, Branch AD. Earlyonset liver fibrosis due to primary hepatitis C virus infection is higher over time in HIV-infected men. Clin Infect Dis 2012; 55: 887-8.
13. Vogel M, Page E, Boesecke C, et al. Liver fibrosis progression after acute hepatitis C virus infection in HIV-positive individuals. Clin Infect Dis 2012; 54: 556-9.
14. Giron-Gonzalez JA, Brun F, Terron A, Vergara A, Arizcorreta A. Natural history of compensated and decompensated HCV-related cirrhosis in HIV-infected patients: a prospective multicentre study. Antivir Ther 2007; 12: 899-907.
15. Lopez-Dieguez M, Montes ML, Pascual-Pareja JF, et al. The natural history of liver cirrhosis in HIV-hepatitis C virus-coinfected patients. AIDS 2011; 25: 899-904.
16. Graham CS, Baden LR, Yu E, et al. Influence of human immunodeficiency virus infection on the course of hepatitis C virus infection: a meta-analysis. Clin Infect Dis 2001; 33: 562-9.
17. Maida I, Nunez M, Rios MJ, et al. Severe liver disease associated with prolonged exposure to antiretroviral drugs. J Acquir Immune Defic Syndr 2006; 42: 177-82.
18. Schiano TD, Uriel A, Dieterich DT, Fiel MI. The development of hepatoportal sclerosis and portal hypertension due to didanosine use in HIV. Virchows Arch 2011; 458: 231-5.
19. Rossi G, Tucci A, Cariani E, Ravaggi A, Rossini A, Radaeli E. Outbreak of hepatitis C virus infection in patients with hematologic disorders treated with intravenous immunoglobulins: different prognosis according to the immune status. Blood 1997; 90: 1309-14.
20. Bjoro K, Skaug K, Haaland T, Froland SS. Long-term outcome of chronic hepatitis C virus infection in primary hypogammaglobulinaemia. QJM 1999; 92: 433-41.
21. Chapel HM, Christie JM, Peach V, Chapman RW. Five-year follow-up of patients with primary antibody deficiencies following an outbreak of acute hepatitis C. Clin Immunol 2001; 99: 320-4.
22. Ok E, Unsal A, Celik A, et al. Clinicopathological features of rapidly progressive hepatitis C virus infection in HCV antibody negative renal transplant recipients. Nephrol Dial Transplant 1998; 13: 3103-7.
23. Delladetsima I, Psichogiou M, Sypsa V, et al. The course of hepatitis C virus infection in pretransplantation anti-hepatitis C virus-negative renal transplant recipients: a retrospective follow-up study. Am J Kidney Dis 2006; 47: 309-16.
24. Shiffman ML, Stravitz RT, Contos MJ, et al. Histologic recurrence of chronic hepatitis C virus in patients after living donor and deceased donor liver transplantation. Liver Transpl 2004; 10: 1248-55.
25. Gane EJ. The natural history of recurrent hepatitis C and what influences this. Liver Transpl 2008; 14(suppl 2):S36-44.
26. Martin P, Di Bisceglie AM, Kassianides C, Lisker-Melman M, Hoofnagle JH. Rapidly progressive non-A, non-B hepatitis in patients with human immunodeficiency virus infection. Gastroenterology 1989; 97: 1559-61.
27. Ridzon R, Gallagher K, Ciesielski C, et al. Simultaneous transmission of human immunodeficiency virus and hepatitis C virus from a needle-stick injury. N Engl J Med 1997; 336: 919-22.
28. Chamie G, Bonacini M, Bangsberg DR, et al. Factors associated with seronegative chronic hepatitis C virus infection in HIV infection. Clin Infect Dis 2007; 44: 577-83.